I have already received approval from the impacted or involved Department chair(s), BUT I have not previously shared and / or obtained e-signature from the impacted or involved Department chair(s) for the IRB for records. Therefore, I have shared this study with the impacted or involved Department chair(s) and (s)he has e-signed this package. I have not yet obtained approval from the impacted or involved Department chair(s). If you selected this response, please share this IRB Submission with the impacted or involved Department chair(s), so that (s)he may electronically sign the submission 9) SIGNATURES The IRBNet package must be electronically signed by the PI before submitting the package to the IRB. If Pharmacy, Pathology, or an additional Department Chair is conducting an ancillary review, please have the designated individual e-sign the submission. If the IBC is reviewing the research, please provide a copy a copy of the IBC approval letter.
I have already received approval from the impacted or involved Department chair(s), BUT I have not previously shared and / or obtained e-signature from the impacted or involved Department chair(s) for the IRB for records. Therefore, I have shared this study with the impacted or involved Department chair(s) and (s)he has e-signed this package. I have not yet obtained approval from the impacted or involved Department chair(s). If you selected this response, please share this IRB Submission with the impacted or involved Department chair(s), so that (s)he may electronically sign the submission 9) SIGNATURES The IRBNet package must be electronically signed by the PI before submitting the package to the IRB. If Pharmacy, Pathology, or an additional Department Chair is conducting an ancillary review, please have the designated individual e-sign the submission. If the IBC is reviewing the research, please provide a copy a copy of the IBC approval letter.
ApplicationforProgressReport2018.03.14.docx